Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Positioning of Esketamine Treatment in the Real-world Management of Depression
NCT06103760Phase 4Recruiting
- Sponsor
- Royal North Shore Hospital
- Start
- Oct 2023
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esketamine in major depressive disorder (MDD), sponsored by Royal North Shore Hospital. Started Oct 2023; status: recruiting.
02
Drugs
esketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06103760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06103760.